Abstract
IntroductionEmicizumab effectively prevents bleeding in people with haemophilia A (PwHA), but is a burden for national healthcare budgets and consequently may limit access. According to the drug label, dosing of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have